A Randomized, Open-Label, Phase I/II Study of ASTX727 Low Dose ASTX727 LD Extended Schedule in Subjects with Lower Risk IPSS Low or Intermediate-1 Myelodysplastic Syndromes MDS

Brief Summary

Type:
Hematologic - Other

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03502668

Study #:
STUDY00142735

Start Date:
Oct 14, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03502668

View Complete Trial Details & Eligibility at ClinicalTrials.gov